TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial

TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial

Authors of this article:

Nikhil Chauhan ¹ ;   Mary F Mulcahy ² ;   Riad Salem ^{2, 3, 4} ;   Al B Benson III ^{2, 5} ;   Eveline Boucher ¹ ;   Janet Bukovcan ¹ ;   David Cosgrove ⁶ ;   Chantal Laframboise ¹ ;   Robert J Lewandowski ^{2, 3, 4} ;   Fayaz Master ¹ ;   Bassel El-Rayes ^{7, 8} ;   Jonathan R Strosberg ⁹ ;   Daniel Y Sze ¹⁰ ;   Ricky A Sharma ¹¹